305 related articles for article (PubMed ID: 26935935)
1. Primary biliary cirrhosis associated with Graves' disease in a male patient.
Suzuki Y; Ishida K; Takahashi H; Koeda N; Kakisaka K; Miyamoto Y; Suzuki A; Takikawa Y
Clin J Gastroenterol; 2016 Apr; 9(2):99-103. PubMed ID: 26935935
[TBL] [Abstract][Full Text] [Related]
2. A patient with primary biliary cirrhosis accompanied by Graves disease and Hurthle cell adenoma.
Yaşar DG; Ozenirler S; Doğan M
Turk J Gastroenterol; 2007 Sep; 18(3):198-200. PubMed ID: 17891696
[TBL] [Abstract][Full Text] [Related]
3. Association of Primary Biliary Cirrhosis-autoimmune Hepatitis Overlap Syndrome with Immune Thrombocytopenia and Graves' Disease.
Koyamada R; Higuchi T; Kitada A; Nakagawa T; Ikeya T; Okada S; Fujita Y
Intern Med; 2015; 54(16):2013-6. PubMed ID: 26278293
[TBL] [Abstract][Full Text] [Related]
4. Development of autoimmune hepatitis in primary biliary cirrhosis.
Gossard AA; Lindor KD
Liver Int; 2007 Oct; 27(8):1086-90. PubMed ID: 17845536
[TBL] [Abstract][Full Text] [Related]
5. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
[TBL] [Abstract][Full Text] [Related]
6. Current Status of Liver Transplantation for Primary Biliary Cholangitis.
Aguilar MT; Carey EJ
Clin Liver Dis; 2018 Aug; 22(3):613-624. PubMed ID: 30259857
[TBL] [Abstract][Full Text] [Related]
7. Management of primary biliary cirrhosis: from diagnosis to end-stage disease.
Lazaridis KN; Lindor KD
Curr Gastroenterol Rep; 2000 Apr; 2(2):94-8. PubMed ID: 10981009
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of primary biliary cirrhosis.
Ali AH; Carey EJ; Lindor KD
Expert Rev Clin Immunol; 2014 Dec; 10(12):1667-78. PubMed ID: 25382237
[TBL] [Abstract][Full Text] [Related]
9. Primary biliary cirrhosis: therapeutic advances.
Czul F; Peyton A; Levy C
Clin Liver Dis; 2013 May; 17(2):229-42. PubMed ID: 23540499
[TBL] [Abstract][Full Text] [Related]
10. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
12. Chronic fatigue should not be overlooked in primary biliary cholangitis.
Shahini E; Ahmed F
J Hepatol; 2021 Sep; 75(3):744-745. PubMed ID: 33640400
[No Abstract] [Full Text] [Related]
13. [Primary biliary cirrhosis (PBC)].
Rautiainen H
Duodecim; 2012; 128(15):1550-9. PubMed ID: 22970606
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome].
Zeng Z; Han YK; Zhang XF; Geng H
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):3-5. PubMed ID: 15670480
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
[TBL] [Abstract][Full Text] [Related]
16. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
[TBL] [Abstract][Full Text] [Related]
17. Primary biliary cholangitis associated with warm autoimmune hemolytic anemia.
Gonzalez-Moreno EI; Martinez-Cabriales SA; Cruz-Moreno MA; Borjas-Almaguer OD; Cortez-Hernandez CA; Bosques-Padilla FJ; Garza AA; Gonzalez-Gonzalez JA; Garcia-Compean D; Ocampo-Candiani J; Maldonado-Garza HJ
J Dig Dis; 2016 Feb; 17(2):128-31. PubMed ID: 26630456
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
[TBL] [Abstract][Full Text] [Related]
19. [Primary biliary cirrhosis: therapeutic options].
Abenavoli L
Recenti Prog Med; 2009 Sep; 100(9):417-23. PubMed ID: 19886235
[TBL] [Abstract][Full Text] [Related]
20. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
Silveira MG; Lindor KD
Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
